Amneal to Participate at Upcoming Investor Conference

Rhea-AI Summary

Amneal Pharmaceuticals (Nasdaq: AMRX) announced that its Co-CEO, Chirag Patel, and CFO, Tasos Konidaris, will participate in the 2024 Jefferies Healthcare Conference on June 5, 2024. Chirag Patel is scheduled to present at 1:30 PM EST. A live webcast of the presentation will be available on the company's website, with a replay accessible after the event.

Positive

• Amneal's participation in a major healthcare conference enhances visibility in the investment community.
• Presentation by key executives can positively influence investor sentiment.
• Availability of live webcast and replay offers broad accessibility to investors and analysts.

Negative

• The press release lacks concrete financial or clinical updates that directly impact stock performance.
• No new product announcements or business developments were mentioned.

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate in the 2024 Jefferies Healthcare Conference on June 5, 2024.

Chirag will present at 1:30 PM EST. A live webcast of the presentation will be accessible on the Company's website at https://investors.amneal.com. A replay of the webcast will be available following the event.

About Amneal

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global pharmaceuticals company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 280 generic and specialty pharmaceuticals, primarily within the United States. In its Generics segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240522763089/en/

Investor Contact:

Anthony DiMeo

VP, Investor Relations & Media

anthony.dimeo@amneal.com

Source: Amneal Pharmaceuticals, Inc.

FAQ

When will Amneal Pharmaceuticals participate in the 2024 Jefferies Healthcare Conference?

Amneal Pharmaceuticals will participate on June 5, 2024.

What time is Chirag Patel's presentation at the Jefferies Healthcare Conference?

Chirag Patel will present at 1:30 PM EST.

Where can I watch the live webcast of Amneal Pharmaceuticals' presentation?

The live webcast will be accessible on Amneal Pharmaceuticals' website at https://investors.amneal.com.

Will there be a replay available for the Amneal Pharmaceuticals presentation at the Jefferies Healthcare Conference?

Yes, a replay of the webcast will be available following the event.